<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03815357</url>
  </required_header>
  <id_info>
    <org_study_id>35266C</org_study_id>
    <nct_id>NCT03815357</nct_id>
  </id_info>
  <brief_title>What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?</brief_title>
  <official_title>What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)? A Prospective Cohort Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Murdoch Childrens Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Murdoch Childrens Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicentre prospective audit to determine the incidence of immunodeficiency in
      children with IPD.

      Aims and/or research question of the project

        1. To determine the incidence of primary immunodeficiency in children &gt;2 years who present
           with IPD

        2. To determine the types of immunodeficiency associated with IPD in children
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2017</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of primary immunodeficiency in children who present with invasive pneumococcal disease</measure>
    <time_frame>3 years</time_frame>
    <description>This will be picked up upon prospective immunological testing, after identification of patients with invasive pneumococcal disease. A series of tests will be performed depending on the clinical opinion of the immunology team. Such tests may include lymphocyte subsets, complement function, serum immunoglobulin levels, memory B cells, vaccine antibody responses, etc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>types of immunodeficiency associated with children who present with invasive pneumococcal disease</measure>
    <time_frame>3 years</time_frame>
    <description>This will be determined based on the testing performed by the immunologists.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>whether increased referrals of children who present with invasive pneumococcal disease for investigation of primary immunodeficiency facilitates early detection</measure>
    <time_frame>3 years</time_frame>
    <description>This information will come from reviewing the case series of patients who are identified from this study. The incidence of those with primary immunodeficiency will be analysed against known background rates of diagnoses.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Invasive Pneumococcal Disease, Recurrent Isolated, 1</condition>
  <condition>Invasive Pneumococcal Disease, Recurrent Isolated, 2</condition>
  <condition>Invasive Pneumococcal Disease, Protection Against</condition>
  <condition>Primary Immunodeficiency</condition>
  <arm_group>
    <arm_group_label>Children with IPD</arm_group_label>
    <description>Children with IPD will be referred for immunological evaluation. The protocol for immune work up will be the same but between centres there is variation in the age criteria for referral i.e. &gt;2 years in some, &gt;6 months in others.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Referral to Immunology</intervention_name>
    <description>Screening for primary immunodeficiency and splenic dysfunction</description>
    <arm_group_label>Children with IPD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children presenting with invasive pneumococcal disease at any of the participating sites
        listed.

        Invasive pneumococcal disease is defined by isolation by culture or PCR of Streptococcus
        pneumoniae from sterile sites including blood, cerebrospinal fluid (CSF), joint fluid or
        pleural fluid. In those patients with bacteraemia, their presentation needs to be
        accompanied by signs of sepsis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 0 to 18 years admitted to one of the six centres with IPD.

        Exclusion Criteria:

          -  Children who do not fulfil the age criteria for immunological evaluation at that
             particular site e.g. aged &lt;2 years at Royal Children's Hospital.

          -  Children with a known underlying condition predisposing to IPD i.e. nephrotic
             syndrome.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Linny K Phuong, MBBS</last_name>
    <phone>61(3)93455522</phone>
    <email>linny.phuong@rch.org.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amanda Gwee, FRACP</last_name>
    <email>amanda.gwee@rch.org.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sydney Children's Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brendan McMullan</last_name>
    </contact>
    <investigator>
      <last_name>Prai Sinnappurajar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brendan McMullan</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine Frith</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Adelaide Women's and Children's Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abigail Cheung</last_name>
    </contact>
    <contact_backup>
      <last_name>Rishi Agarwal</last_name>
    </contact_backup>
    <investigator>
      <last_name>Abigail Cheung</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rishi Agarwal</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Quinn</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3049</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Gwee, FRACP</last_name>
    </contact>
    <investigator>
      <last_name>Linny K Phuong, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amanda Gwee, FRACP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Theresa Cole</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Health</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Kreiser</last_name>
    </contact>
    <investigator>
      <last_name>David Kreiser</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lady Cilento Children's Hospital</name>
      <address>
        <city>Brisbane</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julia Clarke</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Capital and Coast District Health Board</name>
      <address>
        <city>Wellington</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Best</last_name>
    </contact>
    <investigator>
      <last_name>Hazel Dobson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>New Zealand</country>
  </location_countries>
  <reference>
    <citation>Gaschignard J, Levy C, Chrabieh M, Boisson B, Bost-Bru C, Dauger S, Dubos F, Durand P, Gaudelus J, Gendrel D, Gras Le Guen C, Grimprel E, Guyon G, Jeudy C, Jeziorski E, Leclerc F, Léger PL, Lesage F, Lorrot M, Pellier I, Pinquier D, de Pontual L, Sachs P, Thomas C, Tissières P, Valla FV, Desprez P, Frémeaux-Bacchi V, Varon E, Bossuyt X, Cohen R, Abel L, Casanova JL, Puel A, Picard C. Invasive pneumococcal disease in children can reveal a primary immunodeficiency. Clin Infect Dis. 2014 Jul 15;59(2):244-51. doi: 10.1093/cid/ciu274. Epub 2014 Apr 23.</citation>
    <PMID>24759830</PMID>
  </reference>
  <reference>
    <citation>Picard C, Puel A, Bustamante J, Ku CL, Casanova JL. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):451-9. Review.</citation>
    <PMID>14612669</PMID>
  </reference>
  <reference>
    <citation>Alsina L, Basteiro MG, de Paz HD, Iñigo M, de Sevilla MF, Triviño M, Juan M, Muñoz-Almagro C. Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics. PLoS One. 2015 Mar 4;10(3):e0118848. doi: 10.1371/journal.pone.0118848. eCollection 2015.</citation>
    <PMID>25738983</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 12, 2018</study_first_submitted>
  <study_first_submitted_qc>January 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2019</study_first_posted>
  <last_update_submitted>April 14, 2020</last_update_submitted>
  <last_update_submitted_qc>April 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Murdoch Childrens Research Institute</investigator_affiliation>
    <investigator_full_name>Amanda Gwee</investigator_full_name>
    <investigator_title>Infectious Diseases Consultant</investigator_title>
  </responsible_party>
  <keyword>streptococcus pneumoniae</keyword>
  <keyword>invasive pneumococcal disease</keyword>
  <keyword>primary immunodeficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumococcal Infections</mesh_term>
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
    <mesh_term>Immune System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

